Fasiglifam (TAK-875)

DRUG2 trials

Sponsors

Takeda

Conditions

Diabetes Mellitus, Type 2Glycemic Control

Phase 3

Comparison of Fasiglifam (TAK-875) to Placebo and Sitagliptin in Combination With Metformin in Participants With Type 2 Diabetes

TerminatedNCT01549964

TakedaGlycemic Control

Start: 2012-04-30End: 2014-03-31Updated: 2016-06-02

Comparison of Fasiglifam (TAK-875) With Sitagliptin When Used in Combination With Metformin in Patients With Type 2 Diabetes

TerminatedNCT01834274

TakedaDiabetes Mellitus, Type 2

Start: 2013-06-30End: 2014-03-31Updated: 2015-09-28